17β-HSD10-IN-2 is a benzothiazole urea-based inhibitor targeting 17β-hydroxysteroid dehydrogenase type 10 (17β-HSD10), a multifunctional mitochondrial enzyme; it shows no mitochondrial off-target effects, cytotoxicity, or neurotoxicity. Inhibitors of 17β-HSD10 may be used in the research of Alzheimer's disease (AD) and hormone-dependent cancers.